Top compounds associated with response to ASRGL1


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.14 0.0001
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA AS601245 GDSC1000 pan-cancer AAC -0.14 0.0002
mRNA PL-DI CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.12 0.0003
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.12 0.0003
Download CSV